Published in J Virol on February 01, 1991
Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect. J Virol (1994) 3.07
Requirements for the nuclear-cytoplasmic translocation of infected-cell protein 0 of herpes simplex virus 1. J Virol (2001) 2.04
Herpes simplex viruses with mutations in the gene encoding ICP0 are defective in gene expression. J Virol (1992) 1.92
Mutational analysis of the herpes simplex virus type 1 ICP0 C3HC4 zinc ring finger reveals a requirement for ICP0 in the expression of the essential alpha27 gene. J Virol (1997) 1.45
Identification of a dimerization domain in the C-terminal segment of the IE110 transactivator protein from herpes simplex virus. J Virol (1994) 1.39
Physical and functional interactions between herpes simplex virus immediate-early proteins ICP4 and ICP27. J Virol (1997) 1.38
Mapping of intracellular localization domains and evidence for colocalization interactions between the IE110 and IE175 nuclear transactivator proteins of herpes simplex virus. J Virol (1994) 1.37
Alternatively spliced mRNAs predicted to yield frame-shift proteins and stable intron 1 RNAs of the herpes simplex virus 1 regulatory gene alpha 0 accumulate in the cytoplasm of infected cells. Proc Natl Acad Sci U S A (1996) 1.35
Immediate-early transcription from the channel catfish virus genome: characterization of two immediate-early transcripts. J Virol (1995) 0.84
Interaction of herpes simplex virus ICP0 with ND10 bodies: a sequential process of adhesion, fusion, and retention. J Virol (2013) 0.83
The NH2 terminus of the herpes simplex virus type 1 regulatory protein ICP0 contains a promoter-specific transcription activation domain. J Virol (1998) 0.83
Complementation of a herpes simplex virus ICP0 null mutant by varicella-zoster virus ORF61p. J Virol (2009) 0.83
The herpes simplex virus immediate-early ubiquitin ligase ICP0 induces degradation of the ICP0 repressor protein E2FBP1. J Virol (2011) 0.80
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol (1974) 26.25
The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol (1988) 19.25
Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides. Proc Natl Acad Sci U S A (1975) 11.52
Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK. J Virol (1979) 11.34
Fine-structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP175. J Virol (1980) 9.30
Regulation of herpesvirus macromolecular synthesis. V. Properties of alpha polypeptides made in HSV-1 and HSV-2 infected cells. Virology (1977) 8.24
Evidence for a direct role for both the 175,000- and 110,000-molecular-weight immediate-early proteins of herpes simplex virus in the transactivation of delayed-early promoters. J Virol (1985) 7.39
Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. J Mol Biol (1985) 7.32
Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J Gen Virol (1986) 6.74
Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J Virol (1985) 6.67
Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions. Mol Cell Biol (1985) 5.76
Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J Virol (1987) 5.71
Three trans-acting regulatory proteins of herpes simplex virus modulate immediate-early gene expression in a pathway involving positive and negative feedback regulation. J Virol (1985) 5.63
Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene. Proc Natl Acad Sci U S A (1985) 5.40
Physical characterization of the herpes simplex virus latency-associated transcript in neurons. J Virol (1988) 4.85
Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1. Nucleic Acids Res (1986) 4.55
Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts. J Virol (1985) 4.39
Characterization of the IE110 gene of herpes simplex virus type 1. J Gen Virol (1986) 4.19
Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J Virol (1989) 4.18
Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA. J Virol (1989) 3.63
The herpes simplex virus type 1 alpha protein ICP27 can act as a trans-repressor or a trans-activator in combination with ICP4 and ICP0. J Virol (1988) 3.33
The herpes simplex virus latency-associated transcript is spliced during the latent phase of infection. J Virol (1988) 3.22
The products of herpes simplex virus type 1 (HSV-1) immediate early genes 1, 2 and 3 can activate HSV-1 gene expression in trans. J Gen Virol (1986) 3.15
Construction and characterization of herpes simplex virus type 1 mutants with defined lesions in immediate early gene 1. J Gen Virol (1989) 2.97
Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system. J Virol (1989) 2.76
Co-ordinate regulation of herpes simplex virus gene expression is mediated by the functional interaction of two immediate early gene products. J Mol Biol (1986) 2.65
A detailed mutational analysis of Vmw110, a trans-acting transcriptional activator encoded by herpes simplex virus type 1. EMBO J (1987) 2.56
Analysis of the functional domains of herpes simplex virus type 1 immediate-early polypeptide Vmw110. J Mol Biol (1988) 2.46
Reactivation of latent herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene products. J Virol (1990) 2.03
Herpes simplex virus alpha protein ICP27 can inhibit or augment viral gene transactivation. Virology (1989) 1.99
DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci U S A (1979) 21.22
Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell (1979) 21.15
Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell (1978) 19.44
Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell (1977) 18.95
The transfer and stable integration of the HSV thymidine kinase gene into mouse cells. Cell (1978) 6.38
Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene. Proc Natl Acad Sci U S A (1985) 5.40
The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem (1995) 5.36
Altering genotype and phenotype by DNA-mediated gene transfer. Science (1980) 3.82
Introduction and expression of a rabbit beta-globin gene in mouse fibroblasts. Proc Natl Acad Sci U S A (1979) 3.53
Transformation of mammalian cells with an amplifiable dominant-acting gene. Proc Natl Acad Sci U S A (1980) 3.39
Relationship between post-transcriptional adenylation of herpes virus RNA and messenger RNA abundance. Proc Natl Acad Sci U S A (1973) 2.83
Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system. J Virol (1989) 2.76
Isolation of transforming DNA: cloning the hamster aprt gene. Cell (1980) 2.73
Degradation of cellular mRNA during infection by herpes simplex virus. Proc Natl Acad Sci U S A (1977) 2.72
Cervical papillomaviruses segregate within morphologically distinct precancerous lesions. J Virol (1985) 2.70
Co-ordinate regulation of herpes simplex virus gene expression is mediated by the functional interaction of two immediate early gene products. J Mol Biol (1986) 2.65
Macrophages and viral immunity. Semin Hematol (1970) 2.53
Requirement of protein synthesis for the degradation of host mRNA in Friend erythroleukemia cells infected wtih herpes simplex virus type 1. J Virol (1978) 2.51
Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol (1992) 2.37
Transcription: role in the initiation and replication of DNA synthesis in Escherichia coli and phiX174. Biochim Biophys Acta (1971) 2.35
Portability issues for a structured clinical vocabulary: mapping from Yale to the Columbia medical entities dictionary. J Am Med Inform Assoc (1996) 2.24
Pre-mRNA splicing and the nuclear matrix. Mol Cell Biol (1987) 2.22
Isolation and characterization of auxotrophic mutants of Legionella pneumophila that fail to multiply in human monocytes. Infect Immun (1988) 2.10
Reactivation of latent herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene products. J Virol (1990) 2.03
Herpes simplex virus immediate-early promoters are responsive to virus and cell trans-acting factors. J Virol (1987) 1.96
Herpes simplex viruses with mutations in the gene encoding ICP0 are defective in gene expression. J Virol (1992) 1.92
"Transactivation" control signals in the promoter of the herpesvirus thymidine kinase gene. Proc Natl Acad Sci U S A (1985) 1.87
Properties of RNA transcriptase in reovirus subviral particles. Proc Natl Acad Sci U S A (1970) 1.82
Identification of a promoter mapping within the reiterated sequences that flank the herpes simplex virus type 1 UL region. J Virol (1993) 1.77
Cytosine methylation determines hot spots of DNA damage in the human P53 gene. Proc Natl Acad Sci U S A (1997) 1.69
Human papillomavirus type 16 DNA in periungual squamous cell carcinomas. JAMA (1989) 1.65
Introduction of a viral thymidine kinase gene and the human beta-globin gene into developmentally multipotential mouse teratocarcinoma cells. Proc Natl Acad Sci U S A (1980) 1.58
Analysis of the herpes simplex virus type 1 promoter controlling the expression of UL38, a true late gene involved in capsid assembly. J Virol (1991) 1.54
PhenoDB: an integrated client/server database for linkage and population genetics. Comput Biomed Res (1996) 1.54
Dissection of immediate-early gene promoters from herpes simplex virus: sequences that respond to the virus transcriptional activators. J Virol (1987) 1.53
Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. JAMA (1992) 1.51
A polymerase chain reaction-enzyme-linked immunosorbent assay method for detecting human papillomavirus in cervical carcinomas and high-grade cervical cancer precursors. Obstet Gynecol (1995) 1.50
In situ hybridization analysis of HPV 16 DNA sequences in early cervical neoplasia. Am J Pathol (1986) 1.48
Differentiation of Nocardia from rapidly growing Mycobacterium species by PCR-RFLP analysis. Diagn Microbiol Infect Dis (1994) 1.45
Mutational analysis of the herpes simplex virus type 1 ICP0 C3HC4 zinc ring finger reveals a requirement for ICP0 in the expression of the essential alpha27 gene. J Virol (1997) 1.45
Alterations in the protein synthetic apparatus of Friend erythroleukemia cells infected with vesicular stomatitis virus or herpes simplex virus. J Virol (1978) 1.45
Bonded amalgam sealants: two-year clinical results. J Am Dent Assoc (1998) 1.39
Varicella vaccine: the American experience. J Infect Dis (1992) 1.35
Molecular analysis of chromosome-mediated gene transfer. Proc Natl Acad Sci U S A (1979) 1.31
Mutational analysis of the sequence encoding ICP0 from herpes simplex virus type 1. Virology (1991) 1.31
Inhibition of in vitro enteric neuronal development by endothelin-3: mediation by endothelin B receptors. Development (1999) 1.29
Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. Mol Cell Probes (1992) 1.29
Allograft versus autograft anterior cruciate ligament reconstruction: 3- to 5-year outcome. Clin Orthop Relat Res (1996) 1.27
Phenotypic switching in cells transformed with the herpes simplex virus thymidine kinase gene. Mol Cell Biol (1982) 1.18
Alterations in the protein synthetic apparatus of cells infected with herpes simplex virus. Virology (1979) 1.16
Enrollment in and compliance with a community demonstration program of caries prevention for grades kindergarten through 12. J Public Health Dent (1982) 1.12
Control of expression of the herpes simplex virus thymidine kinase gene in biochemically transformed cells. J Gen Virol (1984) 1.11
Multimerization of ICP0, a herpes simplex virus immediate-early protein. J Virol (1992) 1.10
Barriers to computerized prescribing. JAMA (1998) 1.09
Reconstituted human granulocyte-macrophage colony-stimulating factor receptor transduces growth-promoting signals in mouse NIH 3T3 cells: comparison with signalling in BA/F3 pro-B cells. Mol Cell Biol (1993) 1.07
Two overlapping transcription units which extend across the L-S junction of herpes simplex virus type 1. J Virol (1995) 1.05
Replication and recombination in adenovirus-infected cells are temporally and functionally related. J Virol (1984) 1.05
Adenovirus vector expressing functional herpes simplex virus ICP0. J Virol (1988) 1.04
Interaction of zyxin, a focal adhesion protein, with the e6 protein from human papillomavirus type 6 results in its nuclear translocation. J Virol (2001) 1.01
Rapid identification and differentiation of Fasciola hepatica and Fasciola gigantica by a loop-mediated isothermal amplification (LAMP) assay. Vet Parasitol (2010) 0.98
Inhibition by vesicular stomatitis virus of herpes simplex virus-directed protein synthesis. Virology (1983) 0.97
Transduction of the Chinese hamster ovary aprt gene by herpes simplex virus. J Virol (1984) 0.96
Genetic diversity and relatedness of Fasciola spp. isolates from different hosts and geographic regions revealed by analysis of mitochondrial DNA sequences. Vet Parasitol (2011) 0.93
Utilization of deoxyribonucleoside triphosphates in the cellular synthesis of DNA by Bacillus subtilis. Biochem Biophys Res Commun (1971) 0.92
Sensitive and rapid detection of Paragonimus westermani infection in humans and animals by loop-mediated isothermal amplification (LAMP). Parasitol Res (2010) 0.92
Repression of the alpha0 gene by ICP4 during a productive herpes simplex virus infection. J Virol (1996) 0.92
Mental health consultation to a preschool following the murder of a mother and child. Hosp Community Psychiatry (1985) 0.91
The CDC4 gene product is associated with the yeast nuclear skeleton. Biochem Biophys Res Commun (1990) 0.91
Familial café au lait spots: a variant of neurofibromatosis type 1. J Med Genet (1995) 0.91
Hypoxia and modification of the endothelium: implications for regulation of vascular homeostatic properties. Semin Cell Biol (1995) 0.90
Characterization of microRNAs in Taenia saginata of zoonotic significance by Solexa deep sequencing and bioinformatics analysis. Parasitol Res (2011) 0.89
A (R80Q) mutation in 17 beta-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J Clin Endocrinol Metab (1996) 0.89
Papillomavirus infection of the uterine cervix. Microb Pathog (1987) 0.89
Evidence of latent varicella-zoster virus in rat dorsal root ganglia. J Infect Dis (1998) 0.88
Transactivation by herpes simplex virus proteins ICP4 and ICP0 in vaccinia virus infected cells. Virology (1991) 0.87
Enhancer-facilitated expression of prokaryotic and eukaryotic genes using human histone gene 5' regulatory sequences. Biochem Cell Biol (1986) 0.87
[Synthesis of schizandrin C analogs. II. Synthesis of dimethyl-4, 4'-dimethoxy-5, 6, 5', 6'- dimethylenedioxybiphenyl-2, 2'-dicarboxylate and its isomers (author's transl)]. Yao Xue Xue Bao (1982) 0.85
Identification and characterization of microRNAs in Trichinella spiralis by comparison with Brugia malayi and Caenorhabditis elegans. Parasitol Res (2011) 0.84
Both (+/-)syn- and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA- mutations at Codon 61 of c-H-ras. Cancer Res (2000) 0.83
Placental mesenchymal dysplasia associated with transient neonatal diabetes mellitus and paternal UPD6. Placenta (2008) 0.82
Biologic properties and nucleotide sequence analysis of human papillomavirus type 51. J Virol (1991) 0.82
Transformation of mammalian cells with genes from prokaryotes and eukaryotes. 1979. Biotechnology (1992) 0.82
Leprosy research in the post-genome era. Lepr Rev (2001) 0.82
Live attenuated varicella vaccine for prevention of herpes zoster. Biologicals (1997) 0.81
[Synthesis of Schizandrin C analogs (author's transl)]. Yao Xue Xue Bao (1981) 0.80
Congenital varicella-zoster virus infection and Barrett's esophagus. J Infect Dis (1998) 0.79
Differential stability of alpha- and beta-globin mRNAs after infection with herpes simplex virus. FEBS Lett (1978) 0.79
Inhibitory effects of nitric oxide and nitrosative stress on dopamine-beta-hydroxylase. J Biol Chem (2000) 0.78
[Protective effects of Panax notoginseng saponins on experimental myocardial injury induced by ischemia and reperfusion in rat]. Zhongguo Yao Li Xue Bao (1990) 0.78
Increased severity over generations of Charcot-Marie-Tooth disease type 1A. J Neurol (2008) 0.78
Retraction: renaturation of denatured lambda repressor requires heat shock proteins. Cell (1992) 0.78
[Anti-arrhythmic effect of total saponins of Panax notoginseng]. Zhongguo Yao Li Xue Bao (1984) 0.78
A new synthesis of cyclobutanones: highly selective carbonylation of titanacyclobutane complexes prepared by free radical alkylation. J Am Chem Soc (2001) 0.78
Identification of sequences coding for thymidine kinase in herpes simplex virus and transformed cell DNA. IARC Sci Publ (1978) 0.77
Epidermoid carcinoma subsequent to a gunshot wound of the face. J Natl Med Assoc (1984) 0.77